Key Metrics 
Check Before You Invest 
10 Yrs X-Ray 
Valuation 
Analyst Note 
Qtr. Results 
Financials 
News 
About
Dhanvantri Jeevan Rekha Ltd (531043)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 531043 NSE: Hospital & Healthcare Services | Small Cap | DhanvantriJeevan Rek Share Price
₹26 0.81 (3.22%)
As on 28-Sep'26 16:59
Dhanvantri Jeevan Rekha Ltd (531043)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 531043 NSE: Hospital & Healthcare Services | Small Cap | DhanvantriJeevan Rek Share Price
₹26 0.81 (3.22%)
As on 28-Sep'26 16:59
Key Metrics
Valuation Multiples
Market Cap
₹11 Cr.
Current Price
₹26
52-Week Low / High
₹20 / 36
TTM EPS
-
TTM Sales
-
Book Value per Share
-
P/E Ratio
Industry PE
98.6
Price to Book (P/B)
Price to Sales (P/S)
EV/EBITDA
Dividend Yield
0%
Profitability Efficiency
Return on Equity (ROE)
%
Return on Capital Employed (ROCE)
%
Return on Assets (ROA)
%
Operating Profit Margin
0%
Net Profit Margin
-%
Gross Profit Margin
0%
Growth Momentum
1-yr vs 3-yr growth
1-yr vs 3-yr growth
Sales Growth (1 Year)
Improving versus 3-year growth rate
10.7%
Operating Profit Growth (1 Year)
-
-
Net Profit Growth (1 Year)
-
-
Asset Quality
Promoter Holding
19.65%
Pledged shares (%) of Promoter's holding (%)
0.00%
Reserves
-
Equity
₹4.1 Cr.
Face Value
₹10
All Time Low / High
₹3.69 / 61.70
Check Before You Invest
M-Cap below 100cr DeciZen not available
Is Dhanvantri Jeevan Rekha Ltd a good quality company?
Dhanvantri Jeevan Rekha Ltd is a quality company, based on a multi-year financial track record.
This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.
We have analysed the performance of the company on the following:
-
How has it performed on generating Profits?
By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.
-
How efficiently has it utilized Capital?
By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.
-
How is it managing its Debt?
By checking its Debt to Equity and Cash Flow from Operations.
How does Dhanvantri Jeevan Rekha Ltd performance compare with that of its Peers?
Revenue growth of Dhanvantri Jeevan Rekha Ltd vs industry peers?
Dhanvantri Jeevan Rekha Ltd revenue CAGR is %, compared to the industry median CAGR of 4.7%, indicating slower growth and losing its market share.
Promoter shareholding and pledge status of Dhanvantri Jeevan Rekha Ltd?
Promoters hold 19.65% of the Dhanvantri Jeevan Rekha Ltd, with 0.00% of their stake pledged, indicating no pledge risk.
Stock return of Dhanvantri Jeevan Rekha Ltd over the last decade?
Over the last 9 year(s), the stock has delivered a CAGR of 0.1% based on the current price.
10 Year X-Ray :
Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year endData adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.
What is a Financial Track Record? How to read this chart in order to understand the data present here?
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Dhanvantri Jeevan Rekha Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good
Value Creation ⓘ
| Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % ⓘ | 16.7% | 11.8% | 7.9% | 2% | -2.6% | -16.4% | 7.4% | -1.5% | 2.8% | 5.8% | - |
| Value Creation Index ⓘ | 0.2 | -0.2 | -0.4 | -0.9 | -1.2 | -2.2 | -0.5 | -1.1 | -0.8 | -0.6 | - |
Growth Parameters ⓘ |
|||||||||||
| Sales ⓘ | 9.3 | 11.2 | 13.7 | 16.8 | 18.2 | 9.8 | 16.8 | 17.7 | 20.5 | 22.7 | 28 |
| Sales YoY Gr. | - | 20.6% | 23% | 22.5% | 8.2% | -46.3% | 71.4% | 5.5% | 15.7% | 10.7% | - |
| Adj EPS ⓘ | 2.3 | 2.1 | 1.8 | 0.1 | -0.6 | -3.5 | 1.2 | -0.5 | 0.4 | 1.2 | 1.2 |
| YoY Gr. | - | -10.7% | -14.4% | -93.8% | -681.8% | NA | NA | -144.2% | NA | 210% | - |
| BVPS (₹) ⓘ | 22.8 | 24.1 | 25.9 | 26 | 25.4 | 21.9 | 23.1 | 22.6 | 23 | 24.6 | 26 |
| Adj Net Profit ⓘ | 1 | 0.9 | 0.7 | 0.1 | -0.3 | -1.4 | 0.5 | -0.2 | 0.2 | 0.5 | 1 |
| Cash Flow from Ops. ⓘ | 1.3 | 3.5 | 0.9 | 1.3 | 1.4 | -0.4 | 1.1 | -0.4 | 3 | -0.3 | - |
| Debt/CF from Ops. ⓘ | 0 | 0 | 2.2 | 0.1 | 0.1 | -0.2 | 0 | 0 | 0 | 0 | - |
CAGR ⓘ
| 9 Years | 5 Years | 3 Years | 1 Years | |||||
|---|---|---|---|---|---|---|---|---|
| Sales ⓘ | 10.5% | 4.5% | 10.6% | 10.7% | ||||
| Adj EPS ⓘ | -6.8% | NA | 1.1% | 210% | ||||
| BVPSⓘ | 0.8% | -0.6% | 2.1% | 7% | ||||
| Share Price | 0.8% | 22.1% | 31.7% | -12.2% | ||||
Key Financial Parameters ⓘ
| Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity % ⓘ | 10.7 | 8.8 | 7.1 | 0.4 | -2.5 | -14.6 | 5.3 | -2.3 | 1.8 | 5.2 | 4.9 |
| Op. Profit Mgn % ⓘ | 15.6 | 14.4 | 13.5 | 7.3 | 3.7 | -7.7 | 8.9 | 3.3 | 4.1 | 3.2 | 3.2 |
| Net Profit Mgn % ⓘ | 10.3 | 7.6 | 5.3 | 0.3 | -1.5 | -14.6 | 2.9 | -1.2 | 0.8 | 2.2 | 1.8 |
| Debt to Equity ⓘ | 0 | 0 | 0.2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Working Cap Days ⓘ | 174 | 122 | 82 | 71 | 63 | 107 | 72 | 83 | 70 | 58 | 37 |
| Cash Conv. Cycle ⓘ | 24 | 12 | 12 | 20 | 17 | 32 | 22 | 31 | 28 | 17 | 4 |
Valuation of DhanvantriJeevan Rek - Consolidated
Analyst's Notes
No data found!
Management X-Ray
Shareholding Pattern
Promoter's Holding & Share Pledging
| Pledged * | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
* Pledged shares as % of Promoter's holding (%)
Financials
No data found!
No data found!
No data found!
No data found!
Top 5 Mutual Funds Holding
Last Visited Stocks
Announcements
Dhanvantri Jeevan Rekha Ltd FAQs
The current trading price of DhanvantriJeevan Rek on 28-Sep-2026 16:59 is ₹26.00.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 27-Sep-2026 the market cap of DhanvantriJeevan Rek stood at ₹10.66 Cr
The latest P/E ratio of DhanvantriJeevan Rek as of 27-Sep-2026 is 20.89.
The latest P/B ratio of DhanvantriJeevan Rek as of 27-Sep-2026 is 1.00.
The 52-week high of DhanvantriJeevan Rek is ₹35.86 and the 52-week low is ₹19.53.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of DhanvantriJeevan Rek is ₹28.15 ( Cr.) .
Past 10 year’s financial track record analysis by Moneyworks4me indicates that Dhanvantri Jeevan Rekha Ltd is a below average quality company.
The key valuation ratios of Dhanvantri Jeevan Rekha Ltd's currently when compared to its past seem to suggest it is in the Fair zone.
The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Dhanvantri Jeevan Rekha Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.
About Dhanvantri Jeevan Rekha Ltd
Dhanvantri Jeevan Rekha, incorporated on June 11, 1993 is a multi speciality hospital providing reliable diagnostic and therapeutical services. We lay great emphasis on providing good nursing care and clean environment. Dhanvantri hospital has been on the fore front of providing state of art equipment and services in western UP since 1994.
It offers diagnostic and therapeutic facilities in all specialities, well equipped multidisciplinary intensive care units and cashless hospitalization for accredited patients.
The company is basically engaged in offering different medical facilities like Cardiac Care, Endourology, Gastroenterology, Neuro Surgery, Neurology, Anestheslogy and Orthopedic Surgery.
The company was incorporated as a Public Limited Company with the Registrar of Companies in Uttar Pradesh with the main object of providing diagnostic and therapeutic services including Magnetic Resonance Imaging (MRI). The company obtained certificate for commencement of business on August 2, 1993. The company was incorporated with an authorized capital of Rs. 200 Lacs which was subsequently increased to Rs. 500 Lacs from time to time.
In the month of October 1993 the company acquired a constructed building at 1, Saket, Meerut for establishing the Diagnostic Centre. The renovation of the site has already been completed. Diagnostic equipments in the Urology and Cardiology Sections have already been installed and are in operation. The company has acquired the adjacent plot in 2004 on which the future expansion plan is expected to commence shortly.
Services offered by the company:
- Female Urology
- Impotency
- Infertility
- Lithotripsy
- Paediatric Urology
- Cystometrogram
- Uroflowmetry
- Uro Oncology
- Uro Lithiasis
- Stricture Urethra
- Renal Transplant & Dialysis
Future plans :
- A 100 bedded new wing
- 30 bedded ICU.
- Multislice spiral CT scan.
You have 48 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
